Results 101 to 110 of about 811,638 (168)
Genetic characterization of CTX-M-15, AmpC, and metallo-β-lactamase genes among clinical Klebsiella pneumoniae isolates in a tertiary-care hospital [PDF]
Background: The co-existence of Extended-Spectrum β-Lactamases (ESBL), AmpC β-lactamases and Metallo-β-Lactamases (MBL) in Klebsiella pneumoniae limits therapeutic options and complicates infection control in tertiary-care settings.
Swarangi Kulkarni +4 more
doaj
Drug-resistant Klebsiella pneumoniae and related Enterobacterales represent an escalating global public health threat, increasingly limiting therapeutic options in both healthcare- and community-associated infections.
Veronika Zdarska +3 more
doaj +1 more source
INHIBITORS OF METALLO-BETA-LACTAMASES : WO/2018/215800
The present invention relates to certain compounds that function as inhibitors of bacterial metallo-beta-lactamases. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them ...
BELFRAGE, Anna Karin, +6 more
core
Interactions of biapenem with active-site serine and metallo-beta-lactamases.
peer reviewedBiapenem, formerly LJC 10,627 or L-627, a carbapenem antibiotic, was studied in its interactions with 12 beta-lactamases belonging to the four molecular classes proposed by R. P. Ambler (Philos. Trans. R. Soc. Lond. Biol. Sci.
Setacci, D. +16 more
core +1 more source
Prevalence of drug resistant Enterobacteriaceae in a Nepalese tertiary care hospital.
Antimicrobial resistance in Enterobacteriaceae is an emerging global public health problem. Numerous studies have reported community-acquired AmpC beta-lactamase and extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae in Nepal.
Anita Bhandari +7 more
doaj +1 more source
Current Trends in beta-Lactam Based beta-Lactamases Inhibitors
The introduction of antibiotics to treat bacterial infections either by killing or blocking their growth has been accompanied by the development of resistance mechanism that allows the bacteria to survive and proliferate.
Biondi S, Qin WL, Panunzio M, Long S
core
Metallo-β-Lactamases and Aptamer-Based Inhibition
An evolution of antibiotic-resistant bacteria has resulted in the need for new antibiotics. β-Lactam based drugs are the most predominantly prescribed antibiotics to combat bacterial infections; however, production of β-lactamases, which catalyze the ...
Sara R. Schlesinger +6 more
core +1 more source
Background Carbapenemase-producing Enterobacterales pose a serious clinical threat, particularly in high-burden settings of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae (CREK), where rapid detection tools are essential to aid patient ...
Noor Ul Ain +4 more
doaj +1 more source
Dynamically chiral phosphonic acid-type metallo-β-lactamase inhibitors [Elektronisk resurs] [PDF]
Antibiotic resistance is a growing global health threat that risks the lives of millions. Among the resistance mechanisms, that mediated by metallo-beta-lactamases is of particular concern as these bacterial enzymes dismantle most beta-lactam antibiotics,
Haffke, Paul, +62 more
core +1 more source
Se estudiaron 91 aislamientos de Pseudomonas aeruginosa resistentes a carbapenemes con el objetivo de conocer la prevalencia de metalo-β-lactamasas y evaluar la habilidad del ensayo de inhibición empleando discos de EDTA (1 µmol) en su detección. Se
G. Pagniez +7 more
doaj

